ARID1A-induced transcriptional reprogramming rewires signalling responses to drug treatment in melanoma
Resistance to BRAF and MAPK inhibitors is a significant challenge in melanoma treatment,
driven by adaptive and acquired mechanisms that allow tumour cells to evade therapy …
driven by adaptive and acquired mechanisms that allow tumour cells to evade therapy …